DOK7 Antikörper
-
- Target Alle DOK7 Antikörper anzeigen
- DOK7 (Docking Protein 7 (DOK7))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser DOK7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)
- Produktmerkmale
- Homo sapiens docking protein 7 (DOK7), transcript variant 1
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human DOK7(NP_775931) produced in HEK293T cell.
- Klon
- 7E2
- Isotyp
- IgG2a
- Top Product
- Discover our top product DOK7 Primärantikörper
-
-
- Applikationshinweise
- WB 1:2000, IHC 1:150, FLOW 1:100,
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- DOK7 (Docking Protein 7 (DOK7))
- Andere Bezeichnung
- DOK7 (DOK7 Produkte)
- Hintergrund
- The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants.
- Molekulargewicht
- 52.9 kDa
- Gen-ID
- 285489
- NCBI Accession
- NM_173660
- HGNC
- 285489
- Pathways
- Skeletal Muscle Fiber Development
-